…
Allegra Medical Technologies Limited designs, sells, and distributes medical device products in Australia. The company provides adult and adolescent clavicle fixation systems; a range of symmetrical and asymmetrical offsets for shoulder; and StripEase, ChiroKlip, distal radius systems, compression screws, hand fracture systems, ulna shortening plates, and modular ceramic or CoCr heads for heads. It also offers reconstruction prosthesis, modular tumor and revision system, partial pelvis replacement, standard C cementless stem, revision cup, hip acetabular cup system, IP acetabular cup, ceramic prosthesis heads, and CoCrMo prosthesis heads, as well as cemented femoral stem, unipolar head, and cup resector; ActiveKnee, a total knee replacement prosthesis and knee distal first instruments, femoral condyle, nanofracture, arthrodesis nail, modular knee, rotational and hinge knee, and uni knee; and foot and ankle products, such as total ankle replacement systems, DF toe, A-curve handles, screws, activ fuse, and plating system. In addition, the company provides sawblades and kirschner wires and pins. Further, it offers NanoFx, a solution for microfracture procedure; and instrument sets, including post-surgery rehabilitation, shoulder surgery, direct anterior approach, PCL protector, and revision surgery instrument. The company was formerly known as Allegra Orthopaedics Limited and changed its name to Allegra Medical Technologies Limited in November 2023. Allegra Medical Technologies Limited was incorporated in 1994 and is based in Lane Cove West, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | -2.09M | -2.54M | -0.58M | -1.17M | -0.84M |
| Net income | -2.09M | -2.54M | -0.58M | -1.17M | 0.82M |
| Selling general administrative | 1.09M | 1.89M | 1.81M | 1.77M | 1.67M |
| Selling and marketing expenses | - | 0.75M | 0.86M | 0.92M | 1.00M |
| Gross profit | 0.68M | 1.20M | 2.47M | 2.82M | 2.19M |
| Reconciled depreciation | 0.47M | 0.58M | 0.52M | 0.46M | 0.29M |
| Ebit | -1.79M | -4.06M | -3.04M | -2.89M | -2.49M |
| Ebitda | -1.52M | -3.48M | -2.53M | -2.42M | -2.20M |
| Depreciation and amortization | 0.27M | 0.58M | 0.52M | 0.46M | 0.29M |
| Operating income | -1.79M | -1.88M | -0.57M | -1.16M | -2.49M |
| Other operating expenses | 2.45M | 2.83M | 3.12M | 3.13M | 6.25M |
| Interest expense | 0.30M | 0.13M | 0.01M | 0.01M | 0.01M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | 0.30M | 0.00M | 0.00M | 0.01M | 0.01M |
| Net interest income | -0.30M | -0.13M | -0.01M | -0.01M | 0.01M |
| Extraordinary items | -1.56M | -0.52M | - | - | - |
| Income tax expense | - | -0.45M | -0.50M | -0.46M | -1.65M |
| Total revenue | 0.69M | 2.85M | 4.34M | 4.93M | 3.76M |
| Total operating expenses | 2.46M | 5.26M | 5.51M | 5.71M | 4.68M |
| Cost of revenue | 0.01M | 1.65M | 1.87M | 2.11M | 1.57M |
| Total other income expense net | -0.30M | 1.08M | 1.96M | 1.27M | 1.65M |
| Discontinued operations | -1.56M | -0.52M | -0.52M | -0.52M | - |
| Net income from continuing ops | -2.09M | -2.54M | -0.58M | -1.17M | -0.84M |
| Net income applicable to common shares | -3.65M | -2.54M | -0.58M | -1.17M | -0.84M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Total assets | 2.91M | 5.61M | 6.34M | 6.85M | 6.79M |
| Intangible assets | 0.40M | 0.54M | 0.71M | 0.18M | 0.21M |
| Other current assets | 0.94M | 0.13M | 0.16M | 0.08M | 0.14M |
| Total liab | 4.41M | 3.48M | 1.77M | 2.30M | 1.13M |
| Total stockholder equity | -1.50M | 2.13M | 4.57M | 4.54M | 5.67M |
| Deferred long term liab | - | 0.04M | 0.06M | - | - |
| Other current liab | 0.06M | 0.92M | 0.70M | 0.67M | 0.32M |
| Common stock | 15.37M | 15.37M | 15.37M | 14.88M | 14.87M |
| Capital stock | 15.37M | 15.37M | 15.37M | 14.88M | 14.87M |
| Retained earnings | -17.74M | -14.09M | -11.56M | -10.98M | -9.81M |
| Other liab | 0.02M | 0.03M | 0.08M | 0.07M | 0.06M |
| Other assets | 0.00M | 0.14M | 0.17M | 0.11M | 0.10M |
| Cash | 0.00M | 0.21M | 0.36M | 0.76M | 1.08M |
| Cash and equivalents | 0.00M | 0.21M | 0.36M | 0.76M | 1.08M |
| Total current liabilities | 1.71M | 1.58M | 1.60M | 2.23M | 1.06M |
| Current deferred revenue | 0.68M | -0.46M | -0.27M | 0.33M | 0.11M |
| Net debt | 3.13M | 2.13M | -0.01M | -0.59M | -0.99M |
| Short term debt | 0.45M | 0.46M | 0.27M | 0.17M | 0.08M |
| Short long term debt | 0.31M | 0.33M | 0.21M | 0.01M | 0.08M |
| Short long term debt total | 3.13M | 2.33M | 0.36M | 0.17M | 0.08M |
| Other stockholder equity | 0.87M | -1.27M | -3.81M | -3.90M | 5.11M |
| Property plant equipment | 0.32M | 0.58M | 0.70M | 1.06M | 0.97M |
| Total current assets | 2.20M | 4.38M | 4.82M | 5.50M | 5.51M |
| Long term investments | - | 0.11M | 0.11M | 0.11M | 0.10M |
| Net tangible assets | -1.90M | 1.63M | 3.93M | 4.36M | 5.46M |
| Net receivables | 1.14M | 1.20M | 1.27M | 1.43M | 1.16M |
| Long term debt | 2.55M | 1.87M | 0.08M | - | - |
| Inventory | 0.00M | 2.85M | 3.02M | 3.23M | 3.13M |
| Accounts payable | 0.52M | 0.66M | 0.90M | 1.06M | 0.55M |
| Accumulated other comprehensive income | 0.87M | 0.86M | 0.76M | 0.65M | 0.62M |
| Common stock total equity | - | - | - | 14.88M | 14.87M |
| Non currrent assets other | -0.72M | -1.08M | -1.35M | -1.24M | 1.29M |
| Non current assets total | 0.72M | 1.23M | 1.52M | 1.34M | 1.29M |
| Capital lease obligations | 0.27M | 0.14M | 0.06M | 0.16M | - |
| Long term debt total | 2.68M | 1.87M | 0.08M | 0.00M | 0.00M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | 0.07M | -0.11M | -0.12M | -0.14M | -0.05M |
| Change to liabilities | 0.13M | -0.29M | -0.76M | 1.12M | -0.01M |
| Total cashflows from investing activities | 0.07M | -0.11M | -0.12M | -0.14M | -0.05M |
| Net borrowings | 0.43M | 1.75M | -0.16M | -0.22M | -0.04M |
| Total cash from financing activities | 0.43M | 1.81M | 0.09M | -0.00M | 0.57M |
| Change to operating activities | 0.03M | 0.06M | -0.04M | 0.11M | 0.00M |
| Net income | -3.65M | -2.54M | -0.58M | -1.17M | -0.84M |
| Change in cash | -0.27M | -0.16M | -0.39M | -0.32M | -0.54M |
| Begin period cash flow | 0.21M | 0.36M | 0.76M | 1.08M | 1.61M |
| End period cash flow | -0.06M | 0.21M | 0.36M | 0.76M | 1.08M |
| Total cash from operating activities | -0.78M | -1.86M | -0.36M | -0.18M | -1.06M |
| Issuance of capital stock | - | - | 0.01M | 0.01M | - |
| Depreciation | 0.44M | 0.53M | 0.48M | 0.44M | 0.29M |
| Other cashflows from investing activities | 0.11M | 0.11M | 0.11M | 0.11M | 0.00M |
| Dividends paid | - | - | 0.25M | 0.00M | - |
| Change to inventory | 0.08M | -0.35M | 0.21M | -0.11M | -0.10M |
| Change to account receivables | 0.06M | 0.08M | 0.16M | -0.27M | -0.13M |
| Sale purchase of stock | - | 0.00M | -0.00M | -0.00M | 0.00M |
| Other cashflows from financing activities | 0.79M | 1.91M | 0.58M | 0.06M | 0.59M |
| Change to netincome | 2.11M | 0.60M | 0.13M | -0.33M | -0.28M |
| Capital expenditures | 0.03M | 0.11M | 0.12M | 0.14M | 0.05M |
| Change in working capital | 0.14M | -0.28M | 0.37M | -0.38M | 0.00M |
| Stock based compensation | 0.02M | 0.09M | 0.12M | 0.03M | - |
| Other non cash items | 2.44M | 0.14M | -0.26M | 0.55M | 0.55M |
| Free cash flow | -0.81M | -1.97M | -0.48M | -0.32M | -0.05M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| COH Cochlear Ltd |
2.26 1.50% |
152.98 | 68.64 | 27.40 | 4.30 | 5.34 | 3.97 | 28.09 |
| IMR Imricor Medical Systems Inc |
0.06 4.72% |
1.33 | - | - | 36401.21 | 17.45 | 4019.33 | -2.60 |
| AVR Anteris Technologies Global Corp |
0.50 5.88% |
9.00 | - | - | 356.02 | 2.19 | 130.34 | -5.20 |
| AVH Avita Medical Inc |
-0.11 2.13% |
5.06 | - | 9.97 | 9.59 | 7.17 | 6.76 | 15.37 |
Allegra Medical Technologies Limited designs, sells, and distributes medical device products in Australia. The company provides adult and adolescent clavicle fixation systems; a range of symmetrical and asymmetrical offsets for shoulder; and StripEase, ChiroKlip, distal radius systems, compression screws, hand fracture systems, ulna shortening plates, and modular ceramic or CoCr heads for heads. It also offers reconstruction prosthesis, modular tumor and revision system, partial pelvis replacement, standard C cementless stem, revision cup, hip acetabular cup system, IP acetabular cup, ceramic prosthesis heads, and CoCrMo prosthesis heads, as well as cemented femoral stem, unipolar head, and cup resector; ActiveKnee, a total knee replacement prosthesis and knee distal first instruments, femoral condyle, nanofracture, arthrodesis nail, modular knee, rotational and hinge knee, and uni knee; and foot and ankle products, such as total ankle replacement systems, DF toe, A-curve handles, screws, activ fuse, and plating system. In addition, the company provides sawblades and kirschner wires and pins. Further, it offers NanoFx, a solution for microfracture procedure; and instrument sets, including post-surgery rehabilitation, shoulder surgery, direct anterior approach, PCL protector, and revision surgery instrument. The company was formerly known as Allegra Orthopaedics Limited and changed its name to Allegra Medical Technologies Limited in November 2023. Allegra Medical Technologies Limited was incorporated in 1994 and is based in Lane Cove West, Australia.
18-20 Orion Road, Lane Cove West, NSW, Australia, 2066
61 2 9119 9200
| Name | Title | Year Born |
|---|---|---|
| Ms. Jennifer Swain | Chief Exec. Officer | NA |
| Mr. Vincent Wang | Fin. Mang. | NA |
| Mr. Robert Bell | Head of Technology & Innovation | NA |
| Ms. Robyn Slaughter | Company Sec. | NA |
| Ms. Jennifer Swain | Chief Executive Officer | NA |
| Mr. Vincent Wang | Finance Manager | NA |
| Ms. Ellen Newsom | Head of Technology & Innovation | NA |
| Ms. Robyn Slaughter | Company Secretary | NA |
| Ms. Jennifer Swain | Chief Executive Officer | NA |
| Mr. Vincent Wang | Finance Manager | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.